Synthetic 7-OH Kratom More Potent Than Fentanyl, Experts Warn as Third Wave of Products Emerge

Why it matters

For emergency physicians, addiction specialists, and the general public, understanding the escalation from natural kratom to synthetic derivatives is essential. This reporting connects product evolution to clinical outcomes and reveals how patients inadvertently progress from lower-risk to high-risk substances.

The big picture

Kratom's U.S. history has evolved in waves. The first wave (early 2000s) involved powder from dried leaves, popular for opioid withdrawal with low toxicity. The second wave (2015+) introduced enhanced products with concentrated 7-OH. Now a third wave is underway: semi-synthetic compounds like mitragynine pseudoindoxyl—appearing in unregulated candies, gummies, and shots—are substantially more potent than 7-OH itself. One emergency physician describes how a buprenorphine-responsive patient revealed 7-OH's true pharmacology: it behaves identically to opioids.

Key findings

• Natural kratom in traditional use caused few fatalities; enhanced 7-OH products have driven poisonings up 1,200% since 2015
• 7-OH is 50-100x more potent than natural kratom leaf
• Mitragynine pseudoindoxyl is even more potent, described by experts as more potent than fentanyl
• Products sold as kratom include unregulated tablets, capsules, shots, tinctures, drinks, and candy—often in kid-friendly packaging
• One patient escalated from kratom to 7-OH to mitragynine pseudoindoxyl, experiencing withdrawal more severe than fentanyl withdrawal
• The market remains largely unregulated

What they say

Dr. Jeanmarie Perrone (Penn Center for Addiction Medicine) observed: 'Once they started concentrating it in these 7-OH products, it was really replicating a full opioid.' Psychiatrist Corneliu Stanciu added: 'Mitragynine pseudoindoxyl is highly potent—more potent than fentanyl. And they sell it as kratom, even though it has nothing to do with the kratom plant itself.' Perrone warned: 'This is really almost like in the beginning of the prescription opioid epidemic, except you don't need a prescription.'

Bottom line

**Synthetic kratom derivatives—particularly mitragynine pseudoindoxyl—now exceed fentanyl potency and are sold unregulated as flavored candies and drinks, replicating early stages of the prescription opioid crisis.**